New York Senate Bill S09662

New York 2025-2026 Regular Session

• Introduced: 4/1/26
• Refer: 4/1/26

Caption

Directs the commissioner of health to publish guidance for incorporating placenta accreta spectrum screenings into routine prenatal care.

Summary

This bill would add a new section to the Public Health Law directing the Commissioner of Health, in consultation with relevant stakeholders, to publish guidance on incorporating placenta accreta spectrum screenings into routine prenatal care. Placenta accreta spectrum is defined in the bill as a pregnancy complication in which the placenta attaches too deeply into the wall of the uterus. The required guidance would address when screenings should begin and how often they should be repeated during pregnancy, what risk factors should be considered, and how patients should be referred for follow-up evaluation, diagnosis, and treatment. The bill specifically identifies risk factors such as multiple cesarean sections, placenta previa, advanced maternal age, multiparity, and prior uterine surgeries or curettage. The act would take effect 90 days after becoming law.

Impact

The bill would not create a direct mandate for screenings, but it would require the Department of Health to develop statewide clinical guidance and best practices for prenatal providers. Its practical effect would be to standardize how placenta accreta spectrum is identified and managed in routine prenatal care, potentially influencing obstetric screening protocols, referral pathways, and maternal-fetal care across New York. It would amend the Public Health Law by adding section 2500-n.

Sentiment

Based on the bill text and the absence of recorded committee debate or votes, the measure appears to be framed as a public health and maternal care improvement bill with an informational and preventive focus. The overall sentiment is likely supportive, since it seeks to improve early detection and care coordination for a serious pregnancy complication. No formal opposition or recorded controversy is available in the provided materials.

Contention

No committee transcripts or voting history were provided, so there is no documented contention in the record supplied. Potential areas of discussion, if any arise, would likely concern how prescriptive the guidance should be, the burden on prenatal providers, and whether the state should recommend screening protocols for a condition that may require specialized clinical judgment. The bill itself leaves implementation details to the commissioner and consultation with stakeholders, which may reduce controversy.